Filing Details

Accession Number:
0001144204-10-037193
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-08 13:00:00
Reporting Period:
2010-05-28
Filing Date:
2010-07-08
Accepted Time:
2010-07-08 18:50:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1072379 Northwest Biotherapeutics Inc NWBO.OB Pharmaceutical Preparations (2834) 943306718
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289624 F Linda Powers 9306 Kendale Road
Potomac MD 20854
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-05-28 100,000 $1.03 33,573,510 No 4 S Direct
Common Stock Disposition 2010-06-01 7,900 $1.01 33,565,610 No 4 S Direct
Common Stock Disposition 2010-06-02 32,500 $0.97 33,533,110 No 4 S Direct
Common Stock Disposition 2010-06-04 30,000 $0.89 33,503,110 No 4 S Direct
Common Stock Disposition 2010-06-07 79,000 $0.93 33,424,110 No 4 S Direct
Common Stock Disposition 2010-06-09 20,000 $0.82 33,404,110 No 4 S Direct
Common Stock Disposition 2010-06-10 233,552 $0.93 33,170,558 No 4 S Direct
Common Stock Disposition 2010-06-11 200,000 $0.90 32,970,558 No 4 S Direct
Common Stock Disposition 2010-06-14 7,000 $0.91 32,963,558 No 4 S Direct
Common Stock Disposition 2010-06-15 40,048 $0.87 32,923,510 No 4 S Direct
Common Stock Acquisiton 2010-07-02 866,667 $0.75 33,790,177 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrants $0.00 32,443,013 32,443,013 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
32,443,013 32,443,013 Indirect
Footnotes
  1. Includes 750,000 shares of common stock received by Linda F. Powers for board service on the Issuer's Board of Directors, 2,572,710 owned by Linda F. Powers, 11,041,314 shares owned by Toucan Partners and held jointly by Linda F. Powers and her husband Robert Hemphill Jr., and 19,299,486 shares owned by Toucan Capital Fund II, in which Linda F. Powers and her husband, Robert F. Hemphill, comprise the Investment Committee which has management control.
  2. Ms. Powers purchased 866,667 shares of the Company's common stock and warrants to purchase an additional 86,667 shares of Common Stock for a purchase price of $650,000 on the same terms and conditions as other subscribers of the Company's securities during the second quarter of 2010 ($0.75 per share and 10% warrant coverage). The warrants have an exercise price of $0.75 per share of Common Stock and an exercise period of three (3) years
  3. Not applicable: no derivative securities were converted or exercised.
  4. Includes warrants for 86,667 shares of common stock owned by Linda F. Powers, warrants for 10,321,257 shares of common stock owned by Toucan Partners and held jointly by Linda F. Powers and her husband Robert F. Hemphill, and warrants for 22,035,089 shares of common stock owned by Toucan Capital, in which Ms. Powers and Mr. Hemphill comprise the Investment Committee which has management control.
  5. 86,667 warrants are held directly. 32,356,346 warrants are held indirectly.